Biotech China 2014
Ninth Annual International Conference on Frontiers in Cancer Prevention Research
Pennsylvania Convention Center
connected to the Philadelphia Marriott Downtown Hotel
Philadelphia, Pennsylvania
http://www.aacr.org/meetingcalendar
   Speakers
   --------

   N/A

   AACR
   American Association for Cancer Research

   Upcoming Conferences at the Forefront of Cancer Research

   November 7-10, 2010

   Ninth Annual International Conference on Frontiers in Cancer
   Prevention Research

   Chairperson: Eva Szabo Philadelphia, PA

   Please visit http://www.aacr.org/meetingcalendar often for additional
   conferences and program updates.

Schedule of Presentations:

Sunday, November 7, 2010
10:00:00 Educational Sessions 1: Metabolomics: An Emerging Tool for Defining Complex Biological Systems in Health and Disease Steven S. Gross
10:05:00 Untargeted plasma metabolite profiling: Strategies and approaches for comprehensive characterization of gene mutations and drug actions Steven S. Gross
10:15:00 Metabolomics of disease progression Christopher Beecher
10:30:00 Metabolomics as a unique biochemical approach for therapeutic discovery Gary Siuzdak
10:45:00 Educational Sessions-2 : Trends in Epidemiology Research Gloria M. Petersen
10:50:00 Introduction Gloria M. Petersen
11:00:00 Gene, environment, and risk factor interaction in pancreatic cancer Harvey A Risch
11:10:00 Genomic technologies for variant detection: Current and future trends John D Carpten
11:20:00 Molecular genetic research: Translating discovery into risk assessment and genetic testing Gloria M. Petersen
11:30:00 Professional Advancement Session Margaret R. Spitz
11:35:00 Lunch on own
13:00:00 Educational Session- 3 : Epigenetics Ari M. Melnick
13:05:00 The epigenomic programming of cancer cells Ari M. Melnick
13:15:00 DNA methylation, its role in cancer development, and its use as a biomarker James G. Herman
13:30:00 Histone modifying enzymes, their role in cancer, and their therapeutic targeting Kapil N. Bhalla
13:40:00 Educational Session-4 : Team Science and Transdisciplinary Approaches to Cancer Prevention Research Within and Across Institutions Sarah Gehlert
13:45:00 Fostering team science and transdisciplinary approaches to cancer prevention: The Centers for Population Health and Health Disparities experience Sarah Gehlert
14:00:00 Team science and transdisciplinarity in cancer prevention research across the life cycle: The Breast Cancer and the Environment Research Program experience Robert A. Hiatt
14:15:00 The NCI perspective on the significance and importance of team science and transdisciplinarity for cancer prevention research: The TTURC experience Glen Morgan
14:40:00 Educational Sessions - 5: Clinical Trial Novel Design: Retooling Drugs for Prevention Andrea Decensi
14:45:00 Common drugs associated with reduced cancer risk Gad Rennert
15:00:00 Efficient trial designs and suitable cohorts to assess preventive agents Jack Cuzick
15:10:00 Presurgical models to effectively screen preventive agents Andrea Decensi
15:15:00 Educational Sessions - 6: The Indigenous Gut Microbiota in Colon Cancer
15:20:00 Understanding the structure and function of the gut microbiota
15:40:00 Colonic bacteria, inflammation, and colon cancer Cynthia L. Sears
16:00:00 The microbiota and development of colitis-associated colorectal cancer Christian Jobin
16:30:00 Special Session: View From the NCI Robert T. Croyle, Peter Greenwald
18:00:00 Opening Plenary Session
18:05:00 Keynote Address Elizabeth Blackburn
18:30:00 Distinguished Lecture on Targets for Cancer Prevention Inflammation and cancer: Interweaving microRNA, innate immune, and p53 pathways Curtis C. Harris
19:30:00 Opening Reception
Monday, November 8, 2010
07:00:00 Breakfast Session Roundtables
08:30:00 Plenary Session 1: Personalized Prevention Scott M Lippman
08:35:00 Proximity of personalized risk and predictive markers to the clinic Scott M Lippman
08:45:00 Pharmacogenetics of nicotine dependence treatment: Implications for targeted therapy Caryn Lerman
09:00:00 ODC genotype as prognostic and predictive factors in colorectal carcinogenesis and prevention Eugene W. Gerner
09:20:00 Selenium, genes, and cancer prevention Jing Ma
10:15:00 Concurrent Sessions 1 : Infections Douglas R LOWY
10:20:00 Current and future HPV vaccines Douglas R LOWY
10:30:00 Immunotherapy of established lesions caused by high-risk HPV Cornelis J.M. Melief
10:40:00 HBV vaccination to prevent hepatocellular carcinoma Mei-Hwei Chang
10:45:00 Concurrent Sessions 2 : Recently Completed Developmental Trials in Chemoprevention Howard H. Bailey
10:50:00 Randomized, placebo-controlled, double-blind Phase IIB trial of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia Frank L. Meyskens
11:00:00 Randomized phase II trial of genistein in patients with localized prostate cancer Dr. Raymond Bergan
11:10:00 Phase 0 trial of SR13668, an orally active AKT inhibitor Joel M. Reid
11:20:00 Topical chemoprevention of skin cancers Joanne M. Jeter
11:30:00 Discussion Howard H. Bailey
11:35:00 Concurrent Sessions -3 : Interventions to Reduce Cancer Health Disparities Electra D. Paskett
11:40:00 Community-based intervention to reduce liver cancer disparities in Asian Americans: A cluster randomized trial Roshan Bastani
11:45:00 Randomized trial of a lay health advisor and computer intervention to increase mammography screening in African American women Electra D. Paskett
11:50:00 Improving follow-up to abnormal breast cancer screening in an urban population: A patient navigation intervention Tracy Battaglia
11:55:00 Short talk from proffered abstracts
12:00:00 Lunch on own
13:15:00 Concurrent Sessions - 4 : Molecular Targets for Cancer Prevention Eva Szabo
13:20:00 PPARgamma in aerodigestive cancer prevention Eva Szabo
13:30:00 Strategies to target the insulin/IGF-I receptor family for cancer prevention Michael Pollak
13:40:00 PI3K as a target for lung cancer chemoprevention Andrea H. Bild
13:45:00 Concurrent Sessions - 5 : Prostate Cancer Dr. Raymond Bergan
13:50:00 Early molecular changes in prostate carcinogenesis William G. Nelson
14:00:00 The role of estrogen in prostate cancer development and prevention Shuk-Mei Ho
14:10:00 Decision making in prostate cancer screening Kathryn L. Taylor
14:15:00 Concurrent Sessions - 6 : Individualized Diet and Cancer Prevention Johanna W. Lampe
14:20:00 Soy foods and cancer risk: How does the relation vary in individuals with different ethnicity, diet, and lifestyle? Gertraud Maskarinec
14:30:00 Green tea and pomegranate: The role of metabolites in chemoprevention Susanne M. Henning
14:40:00 Vegetable constituents and biotransformation enzymes: The effect of genetic variation on response Johanna W. Lampe
15:15:00 Plenary Session 2: New Approaches to Identifying High-risk Populations Avrum E. Spira
15:20:00 Identifying the smoker at risk for lung cancer Avrum E. Spira
15:30:00 Cancer risk: Stratification through biophotonic detection of field carcinogenesis Hemant K. Roy
15:40:00 Somatic evolution and neoplastic progression in Barrett’s esophagus: Lessons in space and time Brian J. Reid
15:50:00 New insights into genetic susceptibility to breast cancer Douglas Easton
17:15:00 AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research Lecture
18:15:00 Poster Session A
Tuesday, November 9, 2010
07:00:00 Report on AACR-NCI Think Tank: Charting the Future of Cancer Prevention Raymond N DuBois
08:00:00 Plenary Session 3: Bioenergetics and Cancer John A. , Milner
08:05:00 Introduction John A. , Milner
08:15:00 Exercise, BMI, and cancer Anne McTiernan
08:30:00 Nrf2 and cancer protection Rafael de Cabo
08:45:00 Cancer cure and prevention: Lessons learned from a small but highly effective agent Peter Pedersen
09:00:00 Obesity and mTOR signaling George Thomas
10:15:00 Concurrent Sessions 7 : Lung Cancer Prevention Jenny T. Mao
10:20:00 Natural history of bronchial preneoplasia Stephen Lam
10:30:00 Neutrophil elastase links lung cancer and COPD McGarry Houghton
10:40:00 Efficient designs for lung cancer prevention trials: Lessons learned and moving forward J. Jack Lee
10:50:00 Recent studies on mechanisms and prevention of tobacco-induced cancer Stephen S Hecht
11:00:00 Concurrent Sessions 8 : Novel Targets and Strategies for Breast Cancer Prevention Powel H. Brown
11:10:00 Implications of the cancer stem cell hypothesis for breast cancer prevention Max S Wicha
11:20:00 Breast cancer prevention: Predictors and outcomes of patient decision making Suzanne C. O'Neill
11:30:00 PARP inhibitors: Early promise in breast and ovarian cancer prevention Judy E Garber
11:40:00 Concurrent Sessions 9 : Molecular Approaches to Early Detection Samir Hanash
11:45:00 Autoantibodies and early detection of lung cancer Samir Hanash
11:50:00 Novel strategies for the early detection of solid cancers through vascular biomarkers George Coukos
11:55:00 Molecular approaches to early detection of pancreatic cancer Caroline Hollingsworth
12:00:00 Lunch on own
13:15:00 Concurrent Sessions - 10 : The Microenvironment Thea D. Tlsty
13:20:00 Stromal-epithelial interactions in early carcinogenesis Thea D. Tlsty
13:30:00 Stromal signals from the involuting microenvironment that are important in postpartum breast cancer Pepper J Schedin
13:40:00 Profiling of tumors to identify factors that contribute to cancer health disparities Stefan Ambs
13:45:00 Concurrent Sessions 11 : Advances in the Genetics and Treatment of Cancer Susceptibility Syndromes Katherine L. Nathanson
13:50:00 Pheochromocytoma and paraganglioma Katherine L. Nathanson
14:00:00 Clinical trials in neurofibromatosis 1 and 2 Scott Plotkin
14:10:00 Chemoprevention in Lynch syndrome Sir John Burn
14:15:00 Concurrent Sessions 12 : Inflammation and Cancer Prevention Andrew J. Dannenberg
14:20:00 The prostaglandin-aromatase connection: Implications for breast carcinogenesis Andrew J. Dannenberg
14:30:00 The inflammation-EMT-cancer initiating cell axis in the pathogenesis of lung cancer: Breaking ground in the pursuit of targeted chemoprevention Steven Dubinett
14:40:00 The role of inflammation and stromal cells in gastrointestinal cancers Timothy C. Wang
15:15:00 Plenary Session 4: Understanding Neoplastic Progression: Questions and Controversies Carlo C Maley
15:20:00 Evolutionary concepts of cancer Carlo C Maley
15:45:00 Cancer stem cells? Simon Tavare
16:15:00 Title to be announced Alfonso Bellacosa
16:45:00 Why do benign growths so often progress to malignant cancers? John W. Pepper
17:15:00 Poster Session B
Wednesday, November 10, 2010
07:00:00 Breakfast Session Roundtables
08:00:00 Plenary Session 5: Bringing Prevention and Early Detection to the Public: A Global Perspective Michael J. Thun,
08:05:00 Introduction and overview of the global burden of cancer Michael J. Thun,
08:30:00 From basic science to public health: The Canadian approach to oral leukoplakia Miriam P. Rosin
09:00:00 The Australian skin cancer prevention experience: Lessons learned and global challenges ahead Craig Sinclair
10:15:00 Concurrent Sessions - 13 : Colon Cancer Prevention Paul J. Limburg
10:20:00 Immunotherapy for prevention of colorectal cancer Robert E. Schoen
10:30:00 Stool DNA testing to screen colorectal and other aerodigestive cancers David A. Ahlquist
10:40:00 HDAC inhibitors in colorectal cancer chemoprevention Roderick Dashwood
10:50:00 Concurrent Sessions 14 : Head and Neck Cancer Prevention Mary E. Reid
10:55:00 Motivating individual behavior change through theory-driven community engagement Henrietta L. Logan
11:15:00 Implications of fluorescent screening for detection of premalignancy and cancer Mary E. Reid
11:30:00 Identifying the premalignant lesion at high risk for progression to cancer Li Mao
11:40:00 Concurrent Sessions 15 : Communicating Cancer Risks: High-Risk Populations, the Public, and Physician Communication Mary B. Daly
11:45:00 Communicating cancer risk to high-risk patients and their families Mary B. Daly
11:50:00 The importance of form, content, and context in the design and effectiveness of risk communication methods James P Dolan
11:55:00 Making data talk: Communicating science to lay audiences Bradford W. Hesse
12:00:00 Departure
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.